about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersSelecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancersFamilial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskInvolvement of MBD4 inactivation in mismatch repair-deficient tumorigenesisBRCA1 modulates the expression of hnRNPA2B1 and KHSRP.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerHuman MRE11 is inactivated in mismatch repair-deficient cancers.MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.Exploring the link between MORF4L1 and risk of breast cancer.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation.Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas.Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.An intronic mutation in MLH1 associated with familial colon and breast cancer.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationRefined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosisIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.Aetiology of colorectal cancer and relevance of monogenic inheritance.An American founder mutation in MLH1.Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosisHigh prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorPrediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group.BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersCommon variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
P50
Q21144874-CB38C0F2-2246-429A-9830-CD585BE33BF6Q21260381-BA444728-09F7-4149-A86D-7CBD051FFF66Q21260436-F7E9DD1D-B326-49EF-8A8E-B1E28969F95EQ27008356-A2C44CC3-8318-4537-A838-B638E9C2263DQ28269118-320E022D-43BF-49A5-9C12-8813C2E71AA1Q30992379-DDA1FCD8-1B98-4AF2-8518-22FD1939FABAQ31043651-B034F151-7CED-4C6B-9221-D7F4F778C0BDQ33246295-AD654EB5-8F56-49C0-A75D-BB88095AA54BQ33345609-B09CFA08-F262-4536-A28F-032E0C969C23Q33742096-051D429C-B4C8-4C6A-81C2-8DA9491E50C3Q33757629-AF58F485-3586-4D7E-A08B-7F83BD63B5BEQ33765170-EDE3148C-F6D5-414B-B56C-5729FE577608Q33817702-011151BA-A336-400B-8D4E-500CF9DC6238Q33863235-1249A0CD-CFF5-4A66-B020-97E4B048B786Q34081324-9665609F-1684-4850-AD2F-89D67C5228A6Q34084450-AB03DAF5-ED4C-4AC4-A5E3-F5776B23AC15Q34105011-E6701DAF-DCC1-4DA1-B1C5-4DB87CFA9B28Q34273166-A046A671-79C3-486C-AD24-EBEC6DEE10C5Q34394665-5FD2E0A6-E96E-4080-A22F-7E86B6D8FB9EQ34565224-8669ECC6-D8A1-4F9D-B34F-23CBC152DAA8Q34963894-52D4B5AA-EAF5-4C30-9A10-343748E77F06Q35022825-7BCE4BF3-AA5F-4BCA-8D91-43AE8FA3A3A0Q35089479-B0C5B8D0-1D16-44C0-B2AD-A4C87EA2D1F9Q35155449-7BBDF8C1-2513-4DCF-B48C-0B77C58886DFQ35355789-FA92AEC6-6E16-4386-B875-CFD92F0536E6Q35541663-CA798C0F-3A85-4612-8F3C-4240B2B15072Q35596248-28BEE6F8-CBCA-42EE-97E9-9A3486B9B6FFQ35700015-0292EB5E-B101-4A4B-A111-357FBDEAF639Q35746560-404EA58C-9646-40A4-A634-63DC57DECDD7Q35787046-0C7F2688-26D1-442D-882E-8B8E9FBA8258Q35870067-5A41DB8B-110E-44A1-AB38-B20A57631312Q35889575-125751C2-1F4D-4ED2-B024-7625C641C9A9Q35916613-DFB40653-DE2C-49F3-A026-D9F90260BCC4Q35999309-8B87A455-D56E-4C1B-B30A-D1F2194B2C4CQ36356727-D70FCEA2-8B76-456D-AEDC-0F881A0F5289Q36696628-DDD5311A-11D0-402A-ADC9-D3EE411C82CCQ36953347-3F160FAA-36EB-4D55-A50F-26B35A69851DQ37002955-A1B6BE29-6718-4088-B932-685DAF07EC4CQ37434133-2E03A0D8-138A-497C-8745-328CAFC94DF0Q37481884-529E36F4-E312-47CE-9BB6-29D7E8F42943
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandra Viel
@ast
Alessandra Viel
@en
Alessandra Viel
@es
Alessandra Viel
@nl
Alessandra Viel
@sl
type
label
Alessandra Viel
@ast
Alessandra Viel
@en
Alessandra Viel
@es
Alessandra Viel
@nl
Alessandra Viel
@sl
prefLabel
Alessandra Viel
@ast
Alessandra Viel
@en
Alessandra Viel
@es
Alessandra Viel
@nl
Alessandra Viel
@sl
P1053
J-7116-2018
P106
P1153
7005632396
P21
P31
P496
0000-0003-2804-0840